Large Diagnostics Network Inovie serves a broad network of over 1,500 care facilities across multiple care settings (MCO, SSR, EHPAD) with 70 technical platforms and 10 regions, signaling ample cross-selling potential for additional diagnostic services and lab partnerships.

Genomics and Molecules With specialized poles in genomics and molecular biology (IMAGENOME) and anatomical pathology (INOPATH), there are opportunities to upsell advanced molecular testing, precision diagnostics, and concierge pathology services to existing labs and hospitals.

Fertility and Vet Growth Dedicated units for fertility diagnostics (INOVIE Fertilité) and veterinary analyses (ANYDIAG) open adjacent market avenues for expanded testing menus, private-label partnerships, or bundled diagnostic packages for fertility clinics and veterinary networks.

Expansion through Private Equity Recent news of Ardian entering negotiations to acquire a minority stake suggests strategic growth and potential for larger investment in infrastructure, technology upgrades, and geographic expansion—opportunities to position complementary services early in the cycle.

Tech and Digital Readiness A tech stack centered on modern tools (WordPress, Shopify, data tables, CRM-like and marketing platforms) indicates room to implement scalable client portals, digital ordering, and automated reporting that could streamline procurement for the 1,500+ institutions and improve cross-sell efficiency.